The ABO system is one of the major blood groups that have significant impact on blood transfusion and paternity testing. We have found a new ABO allele by analyses of the ABO genotype of the Taiwanese population. Exons 6 and 7 of the ABO gene were amplified by the polymerase chain reaction and analyzed by direct sequencing. The results indicated that the ABO gene in the Taiwanese population con...

Blood group system was discovered way back in 1901 by Karl Landsteiner, Clinically, only ‘ABO’ and ‘Rhesus’ groups are of major importance. ABO blood group distribution varies in different geographical, ethnic and socio-economic groups. Apart from blood transfusion practice, knowing of the ABO and Rh blood groups were useful in population genetic studies, researching population migration patter...

Background/Aim. Due to improved methods for removal of ABO isoagglutinins and novel immunosuppressive protocols, short and long term outcome in blood group incompatible is similar to blood group compatible kidney transplantation. The aim of this study was to determine the efficacy of our original method for removal of ABO isoagglutinins from the blood in ABO-incompatible kidney allograft recipi...

Objectives: To explore the expression of maternal serum IgG anti-A (B) and neonatal direct anti globulin, free antibody and Red Blood Cell (RBC) antibody on the occurrence and development of ABO Haemolytic Disease of the New-born (ABO-HDN) and provide a valuable reference for the early diagnosis of the disease. Methods: we selected 546 cases of jaundice and hyperbilirubinemia neonates in our ho...

Refractoriness occurs in many patients receiving multiple platelet transfusions. We used a sensitive ELISA assay to assess the utility of crossmatching HLA-A,B matched single donor platelets in 51 consecutive, typical refractory patients. Of the 222 transfusions evaluated at 1 to 4 hours posttransfusion, only 17 of 54 (31%) with positive crossmatches had corrected platelet count increments of g...

BACKGROUND & AIMS Living-donor liver transplantation (LDLT) can simultaneously cure hepatocellular carcinoma (HCC) and underlying liver cirrhosis, improving long-term results in patients with HCC. ABO-incompatible LDLT could expand the living-donor pool, reduce waiting times for deceased-donor liver transplantation, and improve long-term survival for some patients with HCC. METHODS We retrosp...

Hemolytic disease of the newborn due to ABO incompatibility was first observed by Halbrecht in 1944. This entity has a spectrum ranging from minimal hemolysis requiring no therapy, as is the case in most instances, to severe hemolytic disease requiring aggressive management including exchange transfusion in a small percentage of cases. An extreme degree of hemolytic disease of the newborn due t...

SANDLER (1970) suggested that mutation, abnormal oocyte (abo:2-38), may influence the function of the ribosomal RNA cistrons. We have examined the abo mutation and its interaction with the ribosomal D N A of Drosophila melanogaster. We observed that the expression of the abo phenotype is unstable under the appropriate conditions, a behavior which paralleled changes in the phenotypic expression ...

BACKGROUND Living-kidney transplantation is increasing because of the scarcity of kidneys from deceased donors and the increasing numbers of patients on waiting lists for a kidney transplant. Living-kidney transplantation is now associated with increased long-term patient- and allograft-survival rates. OBJECTIVES The purpose of this retrospective study was to identify, in a cohort of 44 ABO-i...

BACKGROUND AND AIMS ABO encodes a glycosyltranferase which determines the major human histo-blood group. The FUT2 fucosyltransferase allows expression of ABO antigens on the gastrointestinal mucosa and in bodily secretions (secretor phenotype). A nonsense allele in FUT2 represents a susceptibility variant for Crohn's disease, and both the secretor and ABO blood group status affect the compositi...